Peripheral sensory neuropathy associates with micro- Or microangiopathy: Results from a population-based study of type 2 diabetic patients in Sweden

Diabetes Care

Volumn 32, Issue 2, 2009, Pages 317-322

  Kärvestedt, Lars ^a   Mårtensson, Eva ^b   Grill, Valdemar ^a,c   Elofsson, Stig ^d   Von Wendt, Gunvor ^e   Hamsten, Anders ^a   Brismar, Kerstin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Kronan Primary Health Care Centre   (Sweden)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d STOCKHOLM UNIVERSITY   (Sweden)

^e ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; PERCEPTIVE THRESHOLD; QUESTIONNAIRE; RETINOPATHY; SENSORY NEUROPATHY; URINALYSIS; VASCULAR DISEASE; BLOOD; DIABETIC ANGIOPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; FOOT; MEDICAL RECORD; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PERCEPTION; POPULATION; PREVALENCE; STATISTICS; SWEDEN; VIBRATION;

ADULT; AGED; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEUROPATHIES; DIABETIC RETINOPATHY; FOOT; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MEDICAL RECORDS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERCEPTION; PREVALENCE; QUESTIONNAIRES; SENSORY THRESHOLDS; SUBURBAN POPULATION; SWEDEN; VIBRATION;

EID: 61849124761     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-1250     Document Type: Article

References (25)

1. Bloomgarden ZT: Diabetic retinopathy and neuropathy. Diabetes Care 28:963-970, 2005
2. Boulton AJ, Malik RA, Arezzo JC, Sosenko JM: Diabetic somatic neuropathies. Diabetes Care 27:1458-1486, 2004
3. Wiles PG, Pearce SM, Rice PJ, Mitchell JM: Vibration perception threshold: influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabet Med 8:157-161, 1991
4. Chiarelli F, Santilli F, Mohn A: Role of growth factors in the development of diabetic complications. Horm Res 53:53-67, 2000
5. Brismar K, Lewitt MS: The IGF and IGFBP system in insulin resistance and diabetes mellitus. In IGF and nutrition in health and disease. Houston S, Holly J, Feldman E, Eds., New York, Humana Press Inc., 2004, p. 251-270
6. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, Davis M, Dills D, Ka- mpik A, Pararajasegaram R, Verdaguer JT: Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110:1677-1682, 2003
7. Borg H, Gottsater A, Fernlund P, Sund- kvist G: A 12-year prospective study of the relationship between islet antibodies and β-cell function at and after the diagnosis in patients with adult-onset diabetes. Diabetes 51:1754-1762, 2002
8. Pozzilli P, Di Mario U: Autoimmune diabetes not requiring insulin at diagnosis (latent autoimmune diabetes of the adult): definition, characterization, and potential prevention. Diabetes Care 24:1460-1467, 2001
9. Póvoa G, Roovete A, Hall K: Cross-reaction of serum somatomedin-binding protein in a radioimmunoassay developed for somatomedin-binding protein isolated from human amniotic fluid. Acta Endocrinol (Copenh) 107:563-570, 1984
10. Pirart J: Diabetic neuropathy: a metabolic or a vascular disease? Diabetes 14:1-9, 1965
11. Maser RE, Laudadio C, DeCherney GS: The effects of age and diabetes mellitus on nerve function. J Am Geriatr Soc 41:1202-1204, 1993
12. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, Drash AL, Becker DJ, Kuller LH, Greene DA, Or- chad TJ: Epidemiological correlates of diabetic neuropathy: report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 38:1456-1461, 1989
13. Dyck PJ, Davies JL, Wilson DM, Service FJ, Melton LJ 3rd, O'Brien PC: Risk factors for severity of diabetic polyneurop- athy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort. Diabetes Care 22:1479-1486, 1999
14. El-Asrar AM, Al-Rubeaan KA, Al-Amro SA, Moharram OA, Kangave D: Retinop- athy as a predictor of other diabetic complications. Int Ophthalmol 24:1-11, 2001
15. Adler AI, Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Smith DG: Risk factors for diabetic peripheral sensory neuropathy: results of the Seattle Prospective Diabetic Foot Study. Diabetes Care 20:1162-1167, 1997
16. Adler AI, Stevens RJ, Neil A, Stratton IM, Boulton AJ, Holman RR: UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25:894-899, 2002
17. Pittenger GL, Mehrabyan A, Simmons K, Amandarice, Dublin C, Barlow P, Vinik AI: Small fiber neuropathy is associated with the metabolic syndrome. Metab Syndr Relat Disord 3:113-121, 2005
18. CameronNE, EatonSE, CotterMA, Tesfaye S: Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy. Diabetologia 44:1973-1988, 2001
19. Crosby SR, Tsigos C, Anderton CD, Gordon C, Young RJ, White A: Elevated plasma insulin-like growthfactorbindingprotein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy. Diabetologia 35:868-872, 1992
20. Ishii DN: Implication of insulin-like growth factors in the pathogenesis of diabetic neuropathy. Brain Res Brain Res Rev 20:47-67, 1995
21. Brismar K, Fernqvist-Forbes E, Wahren J, Hall K: Effect of insulin on the hepatic production of insulin-like growth factor- binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 79:872-878, 1994
22. Schmechel H, HeinrichU: Retinopathy and nephropathy in 772 insulin-treated diabetic patients in relation to the type of diabetes. Diabete Metab 19:138-142, 1993
23. Stratton IM, Kohner EM, Aldington SJ, Turner RC, Holman RR, Manley SE, Matthews DR: UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 years from diagnosis. Diabetologia 44:156-163, 2001
24. Coppini DV, Wellmer A, Weng C, Young PJ, Anand P, Sonksen PH: The natural history of diabetic peripheral neuropathy determined by a 12 year prospective study using vibration perception thresholds. J Clin Neurosci 8:520-524, 2001
25. Maguire AM, Craig ME, Craighead A, Chan AK, Cusumano JM, Hing SJ, Silink M, Howard NJ, Donaghue KC: Autonomic nerve testing predicts the development of complications: a 12-year follow-up study. Diabetes Care 30:77-82, 2007